Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Recursion Pharmaceuticals Inc (RXRX)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Recursion Pharmaceuticals's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
8.94 +0.10    +1.13%
16:00:59 - Closed. Currency in USD ( Disclaimer )
After Hours
8.95
+0.01
+0.11%
19:01:09 - Real-time Data
  • Volume: 3,286,885
  • Bid/Ask: 0.00 / 0.00
  • Day's Range: 8.82 - 9.21
Type:  Equity
Market:  United States
Recursion Pharmaceuticals 8.94 +0.10 +1.13%

Recursion Pharmaceuticals Inc Company Profile

 
Get an in-depth profile of Recursion Pharmaceuticals Inc, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

500

Equity Type

ORD

Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase 2 clinical trial to treat cerebral cavernous malformation; REC-2282, which is in Phase 2/3 clinical trial for the treatment of neurofibromatosis type 2; REC-4881, which is in Phase 1b/2 clinical trial to treat familial adenomatous polyposis; REC-3964, which is in Phase 1 clinical trial to treat Clostridioides difficile infection; and REC-4881, which is in Phase 2 clinical trial to treat AXIN1 or APC mutant cancers. Its preclinical stage product includes RBM39 to treat HR-proficient ovarian cancer. The company has collaboration and agreement with Bayer AG; the University of Utah Research Foundation; Ohio State Innovation Foundation; Roche & Genentech; and Takeda Pharmaceutical Company Limited. Recursion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Salt Lake City, Utah.

Contact Information

Address 41 South Rio Grande Street
Salt Lake City, 84101
United States
Phone 385 269 0203
Fax 801 821 2872

Top Executives

Name Age Since Title
Ramon Martin Chavez Marquez 57 2020 Independent Chair of the Board
Robert J. Lollini 70 2014 Member of Business Advisory Panel
Terry-Ann Burrell 47 2020 Independent Director
Joseph P. Miletich 72 2021 Chairman of Therapeutics Advisory Board
Anne Carpenter - 2014 Member of Scientific and Technical Advisory Board
Kirk R. Thomas - 2014 Member of Scientific & Technical Advisory Board
H. Perry Fell 67 2014 Member of Business Advisory Panel
Zavain Dar 35 2016 Independent Director
Dean Y. Li 61 2013 Co-Founder & Independent Director
Zachary S. Bogue 49 2018 Independent Director
Robert M. Hershberg 62 2020 Independent Director
Blake C. Borgeson 42 2013 Co-Founder & Director
Christopher C. Gibson 41 2013 Co-Founder, CEO & Director
Najat Khan - 2024 Chief R&D Officer, Chief Commercial Officer and Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RXRX Comments

Write your thoughts about Recursion Pharmaceuticals Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Bhowani Hiraman
Bhowani Hiraman Apr 10, 2024 20:35
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why is the ceo selling out , look at all other ceo,'s selling
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email